Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers.
Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers.
复制标题
狄诺塞麦与唑来膦酸在延缓胃肠癌、胰胆管系统癌和其他罕见癌症患者骨骼相关事件方面的疗效和安全性。
作者：
Imai H;Saijo K;Yamada H;Ohuchi K;Okada Y;Komine K;Takahashi M;Takahashi S;Takahashi M;Shimodaira H;Ishioka C.
